Skip to Content
 

News: April, 2018

Wilkins takes key role in national ‘All of Us’ precision medicine effort

Monday, April 30th, 2018

Consuelo Wilkins, MD, MSCI, has been appointed director of a new Engagement Core to support the design, implementation and governance of the national All of Us Research Program, an ambitious effort led by the National Institutes of Health (NIH) to accelerate the prevention and treatment of illness through precision medicine.

Funding Opportunity – American Cancer Society-Institutional Research Grant (IRG)

Friday, April 20th, 2018

Applications are being solicited for support by the American Cancer Society‐Institutional Research Grant (IRG). These funds are designed to provide seed money to support junior faculty members with an interest in cancer research who do not have external grant support. Deadline: Monday, May 28, 2018 by 5:00 p.m.

Who should be screened for lung cancer?

Thursday, April 19th, 2018

Lung cancer is the most deadly cancer in the United States – but high-tech imaging now lets smokers get checked for early signs of lung cancer. Finding lung cancer in its earliest stages makes it far easier to treat.

VICC annual scientific retreat set for May 3

Thursday, April 19th, 2018

The annual Vanderbilt-Ingram Cancer Center Scientific Retreat will be held Thursday, May 3, 8 a.m. to 3 p.m. at the Vanderbilt Student Life Center. The potential link between the body’s microbiome and cancer is the topic of this year’s event.

Ingram sees recent cancer diagnosis as second chance

Thursday, April 19th, 2018

Longtime Vanderbilt-Ingram Cancer Center supporter Orrin Ingram opted to take an aggressive approach to treatment when he was diagnosed with prostate cancer.

Agreement renewal bolsters liver tumor research

Friday, April 13th, 2018

Sirtex Medical Ltd. has renewed a grant award to Dan Brown, MD, professor of Radiology and Radiological Sciences and chief of Interventional Oncology, and his Vanderbilt Health colleagues, for a research program designed to treat patients with liver tumors that cannot be addressed with surgery.

VICC breast cancer leaders named Komen Scholars

Friday, April 13th, 2018

Ingrid Mayer, MD, MSCI, Ingram Professor of Cancer Research and leader of the Breast Cancer Research Program, has been named a Komen Scholar for her leadership in breast cancer research. She is joined by Wayne Dornan, PhD, a patient research advocate at VICC, who will serve on the Advocates in Science Steering Committee for Susan G. Komen.

Entertainers’ support strengthens VICC melanoma research efforts

Friday, April 13th, 2018

Henry Paul and Dave Robbins, members of country music group BlackHawk, as well as southern rock band The Outlaws, recently donated $40,000 to Vanderbilt-Ingram Cancer Center (VICC) in support of melanoma research.

“Idling” cancer cells may return

Friday, April 13th, 2018

Vito Quaranta, MD, and colleagues have found that treated melanoma cells enter a previously unrecognized “idling” state. These idling cells may be primed to acquire resistance mutations and may constitute the bulk of residual disease.

VICC to host neurofibromatosis event April 21

Thursday, April 5th, 2018

Vanderbilt-Ingram Cancer Center (VICC) will host a special event for patients and families affected by neurofibromatosis (NF), a genetic disorder that can cause tumors in the nervous system. The Neurofibromatosis Patient and Family Symposium will be held Saturday, April 21, 9 a.m. – 1 p.m., at the VICC 8th floor conference center in the Preston Research Building, 2220 Pierce Ave.